Abstract
Introduction: Nowadays the development of composite nano- and microparticles is an extensively studied area of research. This interest is growing because of the potential use of such particles in drug delivery systems. Indeed they can be used in various medical disciplines depending upon their sizes and their size distribution, which determine their final biomedical applications.
Areas covered: Amongst the different techniques to produce nanoparticles, microfluidic techniques allow preparing particles having a specific size, a narrow size distribution and high encapsulation efficiency with ease. This review covers the general description of microfluidics, its techniques, advantages and disadvantages with focus on the encapsulation of active principles in polymeric nanoparticles as well as on pure drug nanoparticles. Polymeric nanoparticles constitute the majority of the examples reported; however lipid nanoparticulate systems (DNA, SiRNA nanocarriers) are very comparable and their formulation processes are in most cases exactly similar. Accordingly this review focuses also on active ingredient nanoparticles formulated by nanoprecipitation processes in microfluidic devices in general. It also provides detailed description of the different geometries of most common microfluidic devices and the crucial parameters involved in techniques designed to obtain the desired properties.
Expert opinion: Although the classical fabrication of nanoparticles drug delivery systems in batch is extremely well-described and developed, their production with microfluidic tools arises today as an emerging field with much more potential. In this review we present and discuss these new possibilities for biomedical applications through the current emerging developments.
Declaration of interest
The authors have no relevant affiliations or financial involvement with any organisation or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Notes
This box summarizes key points contained in the article.
Khan IU, Serra CA, Anton N, Vandamme T. Microfluidics: a focus on improved cancer targeted drug delivery systems. J Control Release 2013;172(3):1065-74 Dev S, Iyer KS, Raston CL. Nanosized drug formulations under microfluidic continuous flow. Lab Chip 2011;11(19):3214-17 Dev S, Iyer KS, Raston CL. Nanosized drug formulations under microfluidic continuous flow. Lab Chip 2011;11(19):3214-17 Wang JX, Zhanga QX, Zhou Y, et al. Micro fluidic synthesis of amorphous cefuroxime axetil nanoparticles with size dependent and enhanced dissolution rate. Chem Eng J 2010;162:844-51 Wang JX, Zhanga QX, Zhou Y, et al. Micro fluidic synthesis of amorphous cefuroxime axetil nanoparticles with size dependent and enhanced dissolution rate. Chem Eng J 2010;162:844-51 Wang JX, Zhanga QX, Zhou Y, et al. Micro fluidic synthesis of amorphous cefuroxime axetil nanoparticles with size dependent and enhanced dissolution rate. Chem Eng J 2010;162:844-51 Zhang Q-X, Xu L-M, Zhou Y, et al. Preparation of drug nanoparticles using a T-junction microchannel system. Ind Eng Chem Res 2011;50(24):13805-12 Zhang Q-X, Xu L-M, Zhou Y, et al. Preparation of drug nanoparticles using a T-junction microchannel system. Ind Eng Chem Res 2011;50(24):13805-12 Zhang Q-X, Xu L-M, Zhou Y, et al. Preparation of drug nanoparticles using a T-junction microchannel system. Ind Eng Chem Res 2011;50(24):13805-12 Zhu WZ, Wang JX, Shao L, et al. Liquid antisolvent preparation of amorphous cefuroxime axetil nanoparticles in a tube-in-tube microchannel reactor. Int J Pharm 2010;395(1-2):260-5 Zhu WZ, Wang JX, Shao L, et al. Liquid antisolvent preparation of amorphous cefuroxime axetil nanoparticles in a tube-in-tube microchannel reactor. Int J Pharm 2010;395(1-2):260-5 Koh CG, Zhang X, Liu S, et al. Delivery of antisense oligodeoxyribonucleotide lipopolyplex nanoparticles assembled by microfluidic hydrodynamic focusing. J Control Release 2010;141:62-9 Kolishetti N, Dhar S, Valencia PM, et al. Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci USA 2010;107(42):17939-44 Hung LH, Teh SY, Jester J, Lee AP. PLGA micro/nanosphere synthesis by droplet microfluidic solvent evaporation and extraction approaches. Lab Chip 2010;10:1820-5 Rhee M, Valencia PM, Rodriguez MI, et al. Synthesis of size-tunable polymeric nanoparticles enabled by 3D hydrodynamic flow focusing in single-layer microchannels. Adv Mater 2011;23(12):H79-83 Sun J, Xianyu Y, Li M, et al. A microfluidic origami chip for synthesis of functionalized polymeric nanoparticles. Nanoscale 2013;5:5262-5